Advertisement
Organisation › Details
Leo Pharma (Group)
LEO Pharma helps people achieve healthy skin. The company is a leader in medical dermatology with a robust R&D pipeline, a wide range of therapies and a pioneering spirit. Founded in 1908 and majority owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions. LEO Pharma is headquartered in Denmark with a global team of 6,000 people, serving 93 million patients in 130 countries. In 2020, the company generated net sales of DKK 10,133 million. For more information, please visit www.LEO-Pharma.com *
Start | 1908-01-01 established | |
End | 1994-07-01 existent | |
Industry | pharmaceutical | |
Industry 2 | dermatic | |
Person | Aabo, Gitte (Leo Pharma 201511 CEO) | |
Person 2 | Kronborg, Anders (Leo Pharma 201510– EVP Global Finance, IT + Legal before Kinnevik Investment AB) | |
Region | Ballerup | |
Country | Denmark | |
Street | 55 Industriparken | |
City | 2750 Ballerup | |
Tel | +45-44-945888 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | G: 5,001 to 10,000 (2020-04-15) |
Currency | DKK | |
Annual sales | 10,133,000,000 (sales, net, consolidated (2020) 2020-12-31) | |
* Document for »About Section«: Aqilion AB. (12/3/21). "Press Release: Aqilion Strengthens the Company’s Pipeline through the Acquisition of a Phase-1 Ready Anti-inflammatory Program from LEO Pharma". | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Leo Pharma (Group)
- [1] IO Biotech, Inc.. (6/1/23). "Press Release: IO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior Vice President, Commercial and Program Lead". New York, NY....
- [2] Leo Pharma A/S. (1/31/22). "Press Release: Leo Pharma Appoints Christophe Bourdon as New CEO". Ballerup....
- [3] Aqilion AB. (12/3/21). "Press Release: Aqilion Strengthens the Company’s Pipeline through the Acquisition of a Phase-1 Ready Anti-inflammatory Program from LEO Pharma"....
- [4] Pila Pharma AB. (9/24/20). "Press Release: Pila Pharma Announces Positive Phase 2a Results in People with Type 2 Diabetes and Strengthening of the Organization". Malmö....
- [5] Leo Pharma A/S. (4/15/20). "Press Release: Leo Pharma Enters License Agreement with Oneness Biotech and Microbio Shanghai for FB825 a Novel Atopic Dermatitis and Asthma Drug Candidate". Ballerup....
- [6] Bayer AG. (7/2/19). "Press Release: Leo Pharma Completes the Acquisition of Bayer’s Prescription Dermatology Business". Ballerup & Leverkusen....
- [7] Leo Pharma A/S. (6/3/19). "Press Release: Leo Pharma Appoints Catherine Mazzacco as New CEO". Ballerup....
- [8] Cobo Technologies ApS. (4/23/19). "News: Welcome to Our New COO, Hasse Herlevsen"....
- [9] Evotec AG. (12/4/18). "Press Release: Evotec and Leo Pharma Form Drug Discovery Alliance Targeting Dermatological Conditions". Hamburg & Ballerup....
- [10] Leo Pharma A/S. (11/20/18). "Press Release: Leo Pharma and PellePharm Announce $760 Million Collaboration to Advance Innovative Therapies for Rare Skin Diseases". Ballerup & San Francisco, CA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top